ArticleJournal of dental sciences2026

Ovatodiolide overcomes cisplatin resistance in head and neck cancer by disrupting a novel oncogenic signature and cancer-associated fibroblast activation.

Chi-Hsueh Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.